Vendor review
Heman Peptide HM reviews
Heman Peptide HM reviews from 149 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Heman Peptide HM legit? See what its vials showed.
What the lab tests show
149 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 14, 2026 | BPC-157 | 99.99 % | 10.48 mg of 10 mg (5 %) | Pass | View |
| Oct 9, 2026 | GHK-Cu | 99.9 % | 99.99 mg of 100 mg (0 %) | Pass | View |
| Oct 6, 2026 | Ipamorelin | 95.34 % | 11.371 mg of 10 mg (14 %) | Pass | View |
| Sep 25, 2026 | BPC-157 | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 99.8 % | 56 mg of 50 mg (12 %) | Pass | View |
| Sep 24, 2026 | BPC-157 | 99.4 % | 11.9 mg of 10 mg (19 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 90.3 % | 4.21 mg of 5 mg (-16 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 15.5 mg of 15 mg (3 %) | Pass | View |
| Sep 23, 2026 | Retatrutide | 99.9 % | 9.22 mg of 10 mg (-8 %) | Pass | View |
| Sep 21, 2026 | KLOW | 99.9 % | 83.6 mg of 80 mg (4 %) | Pass | View |
| Sep 21, 2026 | KLOW | 99.9 % | 81.18 mg of 80 mg (1 %) | Pass | View |
| Sep 17, 2026 | BPC-157 | 99.9 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Sep 17, 2026 | Ipamorelin | 99.7 % | 9.96 mg of 10 mg (0 %) | Pass | View |
| Sep 17, 2026 | MOTS-c | 98.9 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| Sep 17, 2026 | TB-500 | 98.9 % | 11 mg of 10 mg (10 %) | Pass | View |
| Sep 15, 2026 | GHK-Cu | 99.9 % | 40 mg of 100 mg (-60 %) | Pass | View |
| Sep 14, 2026 | Tirzepatide | 15 mg | Fail | View | |
| Sep 14, 2026 | Tirzepatide | 99.9 % | 32.7 mg of 30 mg (9 %) | Pass | View |
| Sep 10, 2026 | Tesamorelin | 95.1 % | 8.45 mg of 10 mg (-16 %) | Pass | View |
| Sep 10, 2026 | MOTS-c | 98.5 % | 23 mg of 20 mg (15 %) | Pass | View |
| Sep 10, 2026 | NAD+ | 98.1 % | 469 mg of 1000 mg (-53 %) | Pass | View |
| Sep 10, 2026 | SS-31 | 98.9 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Sep 10, 2026 | KPV | 99.9 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Sep 9, 2026 | CJC-1295 | 99.6 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Sep 9, 2026 | Semax | 99.5 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Sep 7, 2026 | GHK-Cu | 99.7 % | 103.4 mg of 100 mg (3 %) | Pass | View |
| Aug 28, 2026 | Retatrutide | 99.7 % | 21.2 mg of 20 mg (6 %) | Pass | View |
| Aug 27, 2026 | Tirzepatide | 95.97 % | 48.9 mg of 40 mg (22 %) | Pass | View |
| Aug 18, 2026 | BPC-157 | 10 mg | Fail | View | |
| Aug 18, 2026 | Retatrutide | 30 mg | Fail | View | |
| Aug 18, 2026 | Tirzepatide | 99.9 % | 34.4 mg of 30 mg (15 %) | Pass | View |
| Aug 18, 2026 | GHK-Cu | 99.6 % | 67.6 mg of 50 mg (35 %) | Pass | View |
| Aug 13, 2026 | GHK-Cu | 99.9 % | 52.7 mg of 50 mg (5 %) | Pass | View |
| Aug 13, 2026 | Retatrutide | 99.9 % | 9.92 mg of 10 mg (-1 %) | Pass | View |
| Aug 13, 2026 | SS-31 | 99.1 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 46.8 mg of 50 mg (-6 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 18.6 mg of 20 mg (-7 %) | Pass | View |
| Aug 12, 2026 | Tirzepatide | 99.9 % | 40.6 mg of 40 mg (2 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 8.79 mg of 10 mg (-12 %) | Pass | View |
| Aug 6, 2026 | GHK-Cu | 99.7 % | 127.4 mg of 100 mg (27 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 36.6 mg of 40 mg (-9 %) | Pass | View |
| Aug 5, 2026 | GHK-Cu | 99.9 % | 59.1 mg of 50 mg (18 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 17.9 mg of 20 mg (-11 %) | Pass | View |
| Aug 5, 2026 | MOTS-c | 98.4 % | 11 mg of 10 mg (10 %) | Pass | View |
| Aug 3, 2026 | BPC-157 | 99.9 % | 8.78 mg of 10 mg (-12 %) | Pass | View |
| Aug 3, 2026 | Tirzepatide | 99.4 % | 16.9 mg of 15 mg (13 %) | Pass | View |
| Aug 3, 2026 | Tirzepatide | 99.7 % | 21.2 mg of 20 mg (6 %) | Pass | View |
| Aug 3, 2026 | Retatrutide | 99.9 % | 17.5 mg of 20 mg (-13 %) | Pass | View |
| Aug 3, 2026 | Tesamorelin | 99.9 % | 9.81 mg of 10 mg (-2 %) | Pass | View |
| Aug 3, 2026 | CJC-1295 | 10 mg | Fail | View | |
| Aug 2, 2026 | Tirzepatide | 99.9 % | 43.6 mg of 40 mg (9 %) | Pass | View |
| Jul 23, 2026 | GHK-Cu | 99.9 % | 44.4 mg of 50 mg (-11 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.8 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.9 % | 52.9 mg of 60 mg (-12 %) | Pass | View |
| Jul 20, 2026 | Retatrutide | 99.8 % | 32.3 mg of 30 mg (8 %) | Pass | View |
| Jul 15, 2026 | Tesamorelin | 98.35 % | 10.12 mg of 10 mg (1 %) | Pass | View |
| Jul 14, 2026 | Glutathione | 99.9 % | 1500 mg of 1500 mg (0 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 20.2 mg of 20 mg (1 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.8 % | 21.6 mg of 20 mg (8 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 11.5 mg of 10 mg (15 %) | Pass | View |
What Heman Peptide HM sells
No current listings on record.
About Heman Peptide HM
Finnrick has tested 149 samples from Heman Peptide HM across 15 products.